Dexrazoxane to Protect Against Hemorrhagic STEMI (NCT07502521) | Clinical Trial Compass
CompletedPhase 2
Dexrazoxane to Protect Against Hemorrhagic STEMI
India50 participantsStarted 2025-08-30
Plain-language summary
This Phase Ila trial evaluates whether the intravenous administration of Dexrazoxane can reduce permanent heart muscle damage in patients undergoing standard stent procedures (PCI) for a severe heart attack (STEMI).
Who can participate
Age range
18 Years – 79 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Adult (18 - 79 years).
. First STEMI (EMS/ER ECG ST-elevation) with primary PCI planned.
. CMR likely be feasible (no known MRI-unsafe implant or absolute MRI prohibition)
Exclusion criteria
. History of PCI or CABG within 1 year
. Known dialysis/ESRD
. Known pre-existing LVEF \<40% from recent records
. Known pregnancy or breastfeeding (history or clearly documented)
. Current anthracycline chemotherapy or active chest radiation (per patient/chart).
. On iron chelation now or documented iron-storage disease (hemochromatosis/thalassemia).
. Concurrent trials: investigational drug or device use within 90 days.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
. Any clinically significant condition identified that would preclude safe peri-procedural administration of Dexrazoxane or completion of core protocol procedures.